Multiple insider selling at Aurora Cannabis (T:ACB)

The following insiders recently exercised Options or Rights and sold shares into the public market.

William Glen Ibbott, CFO, disposed of 100,000 Common Shares on a direct ownership basis at a price of $14.800 on October 16th, 2018. This represents a $1,480,000 divestment of the company's shares and an account share holdings change of -76.9%.

Michael Singer, a Director, disposed of 50,000 Common Shares on a direct ownership basis at a price of $15.070 on October 15th, 2018. This represents a $753,500 divestment of the company's shares and an account share holdings change of -33.3%.

Debra Wilson, a Senior Officer, disposed of 22,000 Common Shares on a direct ownership basis at a price of $15.950 on October 16th, 2018. This represents a $350,900 divestment of the company's shares and an account share holdings change of -99.4%.

Nilda Rivera, a Senior Officer, disposed of 16,666 Common Shares on a direct ownership basis at a price of $13.850 on October 18th, 2018. This represents a $230,824 divestment of the company's shares and an account share holdings change of -14.3%.

Aurora Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in approximately 20 countries worldwide.